A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma (2019–2024)

Grant type:
NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
Researchers:
  • Head Acad & Mayne Chair of Surgery
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
Commonwealth Department of Health